Xiaohong Su

668 total citations
37 papers, 460 citations indexed

About

Xiaohong Su is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Xiaohong Su has authored 37 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 9 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Xiaohong Su's work include Bladder and Urothelial Cancer Treatments (12 papers), Urinary and Genital Oncology Studies (10 papers) and Antifungal resistance and susceptibility (6 papers). Xiaohong Su is often cited by papers focused on Bladder and Urothelial Cancer Treatments (12 papers), Urinary and Genital Oncology Studies (10 papers) and Antifungal resistance and susceptibility (6 papers). Xiaohong Su collaborates with scholars based in China, United States and Rwanda. Xiaohong Su's co-authors include Xuesong Li, Wang Xuemin, Xi Gu, Liqun Zhou, Gengyan Xiong, Dong Fang, Lifang Lin, Peidong Zhang, Shuhu Liu and Xinhong Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biological Psychiatry and The Lancet Oncology.

In The Last Decade

Xiaohong Su

33 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohong Su China 12 173 137 85 63 46 37 460
Yunan Gao China 14 150 0.9× 126 0.9× 85 1.0× 38 0.6× 25 0.5× 30 443
Qiu-Jie Zhao China 5 148 0.9× 58 0.4× 86 1.0× 46 0.7× 54 1.2× 5 371
B. Friedrich Germany 11 225 1.3× 80 0.6× 25 0.3× 41 0.7× 19 0.4× 14 404
Daniel Dumitru Banciu Romania 10 208 1.2× 65 0.5× 36 0.4× 18 0.3× 28 0.6× 24 409
Elia Martha Pérez-Armendáriz Mexico 13 365 2.1× 155 1.1× 25 0.3× 15 0.2× 24 0.5× 21 574
Zhang Chenjing China 10 81 0.5× 103 0.8× 47 0.6× 39 0.6× 45 1.0× 11 325
Daniel Pędziwiatr Poland 13 222 1.3× 40 0.3× 40 0.5× 44 0.7× 45 1.0× 20 464
Lili Huang China 10 230 1.3× 51 0.4× 49 0.6× 20 0.3× 62 1.3× 24 486
Elizabeth S. Silagi United States 11 205 1.2× 119 0.9× 69 0.8× 18 0.3× 14 0.3× 12 628
Xiaofei Ji China 9 214 1.2× 23 0.2× 88 1.0× 19 0.3× 19 0.4× 24 471

Countries citing papers authored by Xiaohong Su

Since Specialization
Citations

This map shows the geographic impact of Xiaohong Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Su more than expected).

Fields of papers citing papers by Xiaohong Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohong Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Su. The network helps show where Xiaohong Su may publish in the future.

Co-authorship network of co-authors of Xiaohong Su

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohong Su. A scholar is included among the top collaborators of Xiaohong Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohong Su. Xiaohong Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Xiaofeng, Xiaohong Su, Lihui Xu, et al.. (2025). Impaired glymphatic function in autoimmune glial fibrillary acidic protein astrocytopathy: a prospective analysis. Multiple Sclerosis and Related Disorders. 99. 106447–106447.
2.
Liu, Junyu, Jia Liu, Lihui Xu, et al.. (2025). Evaluating clinical outcome in non-HIV associated cryptococcal meningitis with negative CSF culture using microscopic quantitative cryptococcal counting. Diagnostic Microbiology and Infectious Disease. 113(2). 116944–116944.
3.
Xu, Xiaofeng, Xiaohong Su, Lihui Xu, et al.. (2025). Clinical features and mortality risk factors in non-HIV elderly patients with cryptococcal meningitis: A retrospective cohort study from 2013 to 2022. PLoS neglected tropical diseases. 19(9). e0013521–e0013521.
4.
Zhang, Yuqin, et al.. (2024). Astrocytic RARγ mediates hippocampal astrocytosis and neurogenesis deficits in chronic retinoic acid-induced depression. Neuropsychopharmacology. 50(2). 419–431. 3 indexed citations
5.
Armenian, Saro H., Melissa M. Hudson, Sitong Chen, et al.. (2024). Effect of carvedilol versus placebo on cardiac function in anthracycline-exposed survivors of childhood cancer (PREVENT-HF): a randomised, controlled, phase 2b trial. The Lancet Oncology. 25(2). 235–245. 10 indexed citations
6.
Luo, Junqi, Taowei Yang, Jun Wu, et al.. (2023). Exosomal PGAM1 promotes prostate cancer angiogenesis and metastasis by interacting with ACTG1. Cell Death and Disease. 14(8). 40 indexed citations
7.
8.
Wang, Yijie, Liping Shen, Xiaohong Su, et al.. (2022). Immunological Predictors of Post Infectious Inflammatory Response Syndrome in HIV-Negative Immunocompetent Cryptococcal Meningitis. Frontiers in Immunology. 13. 895456–895456. 4 indexed citations
9.
Li, Weipeng, Xiaohong Su, Neng-Yuan Hu, et al.. (2022). Astrocytes Mediate Cholinergic Regulation of Adult Hippocampal Neurogenesis and Memory Through M1 Muscarinic Receptor. Biological Psychiatry. 92(12). 984–998. 42 indexed citations
10.
11.
Su, Xiaohong, et al.. (2021). Chronic Administration of 13-cis-retinoic Acid Induces Depression-Like Behavior by Altering the Activity of Dentate Granule Cells. Neurotherapeutics. 19(1). 421–433. 5 indexed citations
12.
Fang, Dong, Nirmish Singla, Xiaohong Su, et al.. (2020). <p>The Significance of Preoperative Serum Sodium and Hemoglobin in Outcomes of Upper Tract Urothelial Carcinoma: Multi-Center Analysis Between China and the United States</p>. Cancer Management and Research. Volume 12. 9825–9836. 3 indexed citations
13.
Su, Xiaohong, et al.. (2020). Transthyretin Regulated by linc00657/miR-205-5p Promoted Cholesterol Metabolism by Inducing SREBP2-HMGCR and Inhibiting LXRα-CYP7A1. Archives of Medical Research. 51(4). 317–326. 10 indexed citations
14.
Su, Xiaohong, et al.. (2020). PVT1 induces NSCLC cell migration and invasion by regulating IL-6 via sponging miR-760. Molecular and Cellular Probes. 54. 101652–101652. 7 indexed citations
15.
Su, Xiaohong, et al.. (2019). Retinoic acid receptor gamma is targeted by microRNA-124 and inhibits neurite outgrowth. Neuropharmacology. 163. 107657–107657. 15 indexed citations
16.
Gu, Xi, Wang Xuemin, Xiaohong Su, et al.. (2018). CBX2 Inhibits Neurite Development by Regulating Neuron-Specific Genes Expression. Frontiers in Molecular Neuroscience. 11. 46–46. 18 indexed citations
17.
Singla, Nirmish, Dong Fang, Xiaohong Su, et al.. (2017). Preoperative predictors of nonorgan-confined disease in upper-tract urothelial carcinoma differ between China and the United States. Urologic Oncology Seminars and Original Investigations. 36(3). 88.e11–88.e18. 14 indexed citations
18.
Su, Xiaohong, Dong Fang, Lei Zhang, et al.. (2016). Treatment strategies for upper tract urothelial carcinoma (UTUC) of a solitary kidney: a single-institutional analysis of 61 cases. International Urology and Nephrology. 48(10). 1601–1608. 2 indexed citations
19.
Weng, Lin, Weiling Wang, Xiaohong Su, et al.. (2015). The Effect of cAMP-PKA Activation on TGF-β1-Induced Profibrotic Signaling. Cellular Physiology and Biochemistry. 36(5). 1911–1927. 35 indexed citations
20.
Marx, Gerald R. & Xiaohong Su. (2007). Three-Dimensional Echocardiography in Congenital Heart Disease. Cardiology Clinics. 25(2). 357–365. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunan Gao Breakdown of academic impact, for papers by Qiu-Jie Zhao Breakdown of academic impact, for papers by B. Friedrich Breakdown of academic impact, for papers by Daniel Dumitru Banciu Breakdown of academic impact, for papers by Elia Martha Pérez-Armendáriz Breakdown of academic impact, for papers by Zhang Chenjing Breakdown of academic impact, for papers by Daniel Pędziwiatr Breakdown of academic impact, for papers by Lili Huang Breakdown of academic impact, for papers by Elizabeth S. Silagi Breakdown of academic impact, for papers by Xiaofei Ji
Rankless by CCL
2026